Annual Report

Overview

The report describes Pierre Fabre Laboratories' 2024 acceleration, with consolidated net sales of EUR 3,072 million and 70% of revenue from international business. It reports 64% renewable energy, a 24% reduction in Scope 1 and 2 CO2 emissions between 2019 and 2023, and a 46% reduction target by 2030, alongside a net-zero impact target for 2050. Patient-focused highlights include 90 active patient-association partnerships and the EczemaCare+ app, which supports 11,000 users.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2024
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services